对帕金森病痴呆症的辅助技术的跨学科方法
Sara Munzesheimer1, Tin Wai Tiffany Siu2, Dudley Yacinthe1
1Department of Physical Therapy, University of Miami Miller School of Medicine, Miami, FL, USA.
Clinical interventions in aging
|August 21, 2025
概括
辅助技术可以提高帕金森病痴呆症 (PDD) 和帕金森病轻度认知障碍 (PD-MCI) 患者的日常功能和安全性. 本综述指导临床医生使用AT来改善PDD/PD-MCI患者的生活质量.
科学领域:
- 神经科学
- 康复医学
- 辅助技术
背景情况:
- 帕金森病痴呆症 (PDD) 和帕金森病轻度认知障碍 (PD-MCI) 是帕金森病 (PD) 中普遍存在的非运动症状.
- 在PDD/PD-MCI的认知衰退显著影响了沟通,安全,独立,社会关系和照顾者的负担.
- 辅助技术为缓解这些挑战和改善生活质量提供了潜在的解决方案.
研究的目的:
- 对患有PDD和PD-MCI的个人进行可用的辅助技术 (AT) 的审查.
- 从跨学科的康复角度分析AT的广度,功能,有效性和利用.
- 为PDD/PD-MCI管理中适当使用和适应AT提供临床指南.
主要方法:
- 对PDD和PD-MCI的AT现有文献进行系统审查.
- 从物理治疗,职业治疗和语言病理学的跨学科见解来考虑AT研究的分析.
- 评估研究的局限性,包括样本大小和专注于PDD/PD-MCI的具体需求.
主要成果:
- 不同的治疗方法可以改善PDD/PD-MCI患者的日常功能,安全和生活质量.
- 一些更大规模的研究提供了对实际AT实施的宝贵见解.
- 目前研究的局限性包括样本规模较小和认知缺陷的不足.
结论:
- 对于患有PDD/PD-MCI的患者及其照顾者来说,辅助治疗可能会带来很大的好处.
- 这一综述是AT选择和适应的跨学科指南.
- 需要进一步研究以了解PDD/PD-MCI中最佳的AT应用,培训和实施.
相关概念视频
01:24Parkinson's Disease: Treatment
377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
01:15Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
01:30Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165